Clindamycin Suppresses Endotoxin Released by Ceftazidime-Treated Escherichia coli O55:B5 and Subsequent Production of Tumor Necrosis Factor Alpha and Interleukin-1β

Treatment of septicemia caused by Escherichia coli with ceftazidime (CAZ) may be associated with the development of septic shock due to the release of bacterial lipopolysaccharide. We examined the suppressive effect of clindamycin (CLDM) on CAZ-induced release of endotoxin by cultured E. coli and th...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kishi, Kenji, Hirai, Kazuhiro, Hiramatsu, Kazufumi, Yamasaki, Tohru, Nasu, Masaru
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 1999
נושאים:
Biologic Response Modifiers
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC89169/
https://ncbi.nlm.nih.gov/pubmed/10049276
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים